Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

How Lilly’s sustainability goals come face to face with massive growth
Pharma Voice
Thu, 09/12/24 - 10:17 am
Tags:
Eli Lilly, drug manufacturing, sustainability
Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate
Fierce Biotech
Wed, 09/11/24 - 11:07 pm
Tags:
Eli Lilly, efsitora, diabetes, insulin
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
Tags:
weight loss, obesity, Amgen, Pfizer, Roche, Novo Nordisk, Eli Lilly, Boehinger Ingelheim, Structure Therapeutics, Viking Therapeutics, Zealand Pharma, Altimmune
Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic
Fierce Biotech
Mon, 09/9/24 - 10:46 am
Tags:
Eli Lilly, Superluminal Medicines, funding, small molecule drugs
57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65
Forbes
Thu, 09/5/24 - 10:29 pm
Tags:
obesity, GLP-1, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, insurers
Eli Lilly says experimental insulin could mean 313 fewer injections per year
Quartz
Thu, 09/5/24 - 11:50 am
Tags:
Eli Lilly, long-acting insulin, diabetes, clinical trials, efsitora
Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Reuters
Thu, 09/5/24 - 11:38 am
Tags:
Eli Lilly, Genetic Leap, drug development, artificial intelligence
BioAge files for IPO, plans pair of midstage obesity trials
Fierce Biotech
Wed, 09/4/24 - 11:40 am
Tags:
BioAge Labs, IPOs, Eli Lilly, obesity, clinical trials
Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets
Fierce Biotech
Wed, 09/4/24 - 11:37 am
Tags:
Eli Lilly, Haya Therapeutics, dark genome, obesity, drug discovery
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
Tags:
obesity, suicide, GLP-1, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro, Zepbound
Eli Lilly partner Hutchmed scraps China stomach cancer filing as approval seems unlikely
Fierce Pharma
Fri, 08/30/24 - 11:40 am
Tags:
Hutchmed, Eli Lilly, Fruzaqla, China, stomach cancer
Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats
Stat
Wed, 08/28/24 - 09:24 pm
Tags:
Eli Lilly, Zepbound, DTC
Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount
Fierce Pharma
Tue, 08/27/24 - 11:51 am
Tags:
Eli Lilly, Zebound, DTC
Lilly launches smallest single-dose vials of Zepbound for $399
Reuters
Tue, 08/27/24 - 11:16 am
Tags:
Eli Lilly, Zepbound
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
Pharmaphorum
Mon, 08/26/24 - 10:14 am
Tags:
Alzheimer's disease, physicians, Eli Lilly, Kisunla, donanemab, lecanemab
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
Fierce Biotech
Thu, 08/22/24 - 11:55 am
Tags:
Eli Lilly, Oblique Therapeutics, AbiProt, drug discovery, antibodies
Lilly’s tirzepatide cuts diabetes risk, study data show
BioPharma Dive
Tue, 08/20/24 - 11:54 am
Tags:
Eli Lilly, tirzepatide, Mounjaro, Zepbound, type 2 diabetes, diabetes, clinical trials
After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly
Fierce Pharma
Tue, 08/20/24 - 11:34 am
Tags:
Organon, Europe, Eli Lilly, Emgality, Rayvow, migraines
'We're pretty prolific': Lilly Catalyze360 looks to connect with emerging biotechs across 'all areas'
Fierce Biotech
Mon, 08/19/24 - 11:10 am
Tags:
Eli Lilly, Lilly Catalyze360, innovation, business development
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
Motley Fool
Sun, 08/18/24 - 09:19 pm
Tags:
Eli Lilly, FDA, obesity, Zepbound

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.